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Rites of passage
Graduates celebrated at recognition
and hooding events across the School
of Medicine at Washington University’s
151st Commencement held on May 18.
Ceremonies recognized medical students,
graduates of the school’s
see more
medicine.wustl.edu programs in Occupational
Therapy, Physical Therapy
and Audiology and Communication
Sciences, and doctoral graduates from
the Division of Biology and Biomedical
Sciences. At left, former students prepare
to join their families and friends following
Commencement at America’s Center in
downtown St. Louis.
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Viruses, bacteria and fungi abound in healthy people

T

rillions of microbes inhabit the
human body, occupying virtually
every nook and cranny. And most
of the time, this relationship is a friendly
one, with microbes helping to digest food,
strengthen the immune system and ward
off dangerous pathogens.
But despite microbes’ prominent roles,
researchers have understood little about
which of them reside in specific sites of
the body. Now, a consortium of some
200 U.S. scientists reports findings from
the most comprehensive census of the
microbial makeup of healthy humans.
The research, published June 14, 2012,
in Nature and in several Public Library of
Science (PLoS) journals, offers new details
and even some surprises.
For example, the researchers found that
even healthy people typically carry low
levels of harmful bacteria in and on their
bodies. But when a person is healthy, these
2 Washington University School of Medicine

pathogens don’t cause disease; they simply coexist in an abundance of beneficial
microbes. Now, scientists can investigate
why some pathogens suddenly turn deadly,
which will refine current thinking on how
microorganisms cause disease.
“It’s not possible to understand human
health and disease without exploring the
massive community of microorganisms
we carry around with us,” says George M.
Weinstock, PhD, associate director of The
Genome Institute at Washington University

Scientists identified
more than 10,000 species
of microbes that occupy
the human ecosystem,
documenting the impressive
diversity of microbial life in
the human body.

and one of the project’s principal investigators. “Knowing which microbes live in various
ecological niches in healthy people allows
us to better investigate what goes awry in
diseases that are thought to have a microbial link, like Crohn’s and obesity, and why
dangerous pathogens sometimes, but not
always, cause life-threatening illnesses.”
Washington University and its Genome
Institute played a major role in the research,
known as the Human Microbiome Project.
The five-year initiative was funded with
$153 million from the National Institutes of
Health (NIH), with some $32 million coming
to Washington University.
Genome Institute scientists decoded
about half of the 5,000 specimens from
nearly 250 healthy volunteers.
“Data generated from this study has the
added potential to provide scientists with
new insights into how local environments
shape the composition of microbes that are
found in healthy individuals,” says co-investigator Mark A. Watson, MD, PhD, associate
professor of pathology and immunology.
Autumn 2012
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Microbial zoo

The bacterium Enterococcus faecalis, which lives in
the human gut, is just one type of microbe studied as
part of the Human Microbiome Project funded by the
National Institutes of Health (NIH).

Global team of scientists to
study childhood malnutrition

U.S. DEPARTMENT OF AGRICULTURE / ERIC YOUNG

Jeffrey I. Gordon, MD, the Dr. Robert J. Glaser Distinguished
University Professor and director of Washington University’s
Center for Genome Sciences and Systems Biology, will lead
an international team of scientists to find new ways to diagnose, treat and prevent a critical global health problem: malnutrition in infants and children. The work is funded by an
$8.3 million grant from the Bill & Melinda Gates Foundation.
Gordon’s research first established a link between obesity
and the trillions of friendly microbes that live in the intestine, where they extract nutrients and calories from food.
His studies have shown that diet helps shape the mix of
microbes in the intestine and that these microbes, in turn,
influence how efficiently nutrients and calories are harvested
from foods. This dynamic interplay has led Gordon to suspect that an imbalance of certain types of gut microbes
conspires with an inadequate diet to trigger malnutrition.
“A complex relationship exists between diet, gut
microbial communities and the immune system in severely
malnourished children,” says Gordon. “We now have a
way to tease apart these influences. This project seeks to
discover novel dietary and microbial therapeutics that can
be targeted to infants and children living in countries with
rampant malnutrition.”
Severe malnutrition
The new research builds
has long been thought to
on ongoing clinical studies
stem simply from a lack of
in Africa, South Asia
adequate food. But now
and South America of
scientists understand the
condition is far more commalnourished and healthy
plex and may involve a
infants and children and
breakdown in the way gut
their mothers.
microbes process various
components of the diet.
The community of intestinal microbes and their vast
collection of genes, known as the gut microbiome, are
assembled right from birth and influenced by babies’ early
environments and the first foods they consume, such as
breast milk. As part of the Breast Milk, Gut Microbiome and
Immunity Project, Gordon will work with other scientists to
evaluate the relationship among first foods, the developing
community of microbes in the intestine and the developing
immune system.
Gordon’s research underscores the need to understand the
workings of gut microbiomes among people of different ages
living in different parts of the world, especially as scientists
consider manipulating intestinal microbes to improve health
and nutrition.
outlook.wustl.edu
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Washington University to lead effort

Summer school Lawrence M. Lewis, MD, professor of
emergency medicine, studies a sonogram in the emergency room
with Amanda Fletcher, a student from Meharry Medical College.
Fletcher and 10 other Meharry students visited Washington University
School of Medicine over the summer to participate in a program
coordinated by the Office of Medical Student Research. Each student
is paired with a faculty mentor and given the opportunity to conduct
research. Fletcher is studying whether higher health literacy
correlates with better self-management of hypertension. As part
of her experience, she is shadowing Lewis in the emergency room
and interviewing patients.

Pediatric quintet tapped as leaders
Washington University’s Department of Pediatrics and
St. Louis Children’s Hospital once again have been catapulted
into the national spotlight — this time by the simultaneous
election of five pediatric faculty into the
top national leadership roles in large
and distinguished medical societies.
Thomas W. Ferkol Jr., MD, was
installed as vice president of the
American Thoracic Society. Keith A.
Hruska, MD, was elected president of
the American Society for Bone and
Mineral Research. David M. Jaffe,
MD, was installed as president of the
Academic Pediatric Association. Alan
L. Schwartz, PhD, MD, will become
president of the American Pediatric
Society. Gregory A. Storch, MD, is
president-elect of the Pan American
Society for Clinical Virology.
“Election to lead a major academic society is a mark
of distinction,” says Schwartz, the Harriet B. Spoehrer
Professor and head of the Department of Pediatrics. “We are
very proud of the recognition of Drs. Ferkol, Hruska, Jaffe
and Storch by their peers nationally. This is a most unusual
concurrence, and one that highlights Washington University
School of Medicine.”
Outlook 3

Workers prepare to place a
new MRI scanner into the
East Building at Washington
University School of
Medicine. The 18,000-pound
scanner, delivered in June, is
customized for use in the Human
Connectome Project, a research study
that will trace the anatomical and functional
connections between different regions of the human brain. David C.
Van Essen, PhD, the Edison Professor and head of the Department of
Anatomy and Neurobiology, is co-investigator of the project, which
began scanning brains of research participants in August. The project
aims to compile unparalleled neural data and to create an interface
to graphically navigate this information.

Dacey heads neurosurgery society
Ralph G. Dacey Jr., MD, the Henry G. and Edith R. Schwartz
Professor and head of the Department of Neurosurgery, is
now president of the Society of Neurological Surgeons (SNS).
The SNS is the American society of leaders in neurosurgical residency education and is the oldest neurosurgical
society in the world. Dacey, who is neurosurgeon in chief at
Barnes-Jewish Hospital, joins an exclusive group of neurosurgical leaders that includes Harvey
W. Cushing, MD, who is regarded
as the father of modern neurosurgery and served as the SNS’s first
president in 1920. Additionally, each
of Dacey’s predecessors as head of
the Department of Neurosurgery
served terms as president of the SNS:
Ernest Sachs, MD, the first professor
of neurological surgery in the
world and founding director of the
Department of Neurological Surgery
at the School of Medicine; Henry G.
Ralph G. Dacey Jr., MD
Schwartz, MD; and Sidney Goldring,
MD. Sachs was a founding member of the society in 1920.
The group’s goals include promoting improvements
in education and training for neurosurgical students and
postgraduates; recognizing outstanding neurosurgical care,
instruction and research; and encouraging the highest
standards of care for patients with neurological diseases.
Dacey plans to work with the Accreditation Council for
Graduate Medical Education to optimize a new set of procedures for accrediting neurosurgical training programs and
to establish a web portal to help meet the educational needs
Enjoy interactive elements and added content
of neurosurgeons at every point in their careers, from
neurosurgical residents to practicing neurosurgeons.
4 Washington University School of Medicine

Examining the link between
diabetes and heart disease
Grant to fund collaborative research
Researchers at the School of Medicine have received a
$4.7 million grant from the National Heart, Lung, and Blood
Institute to investigate heart disease in patients with diabetes.
“Diabetes is an incredibly common problem,” says Jean E.
Schaffer, MD, the Virginia Minnich Distinguished Professor
of Medicine. “It affects a huge swath of the population.
Importantly, people with diabetes don’t just have a metabolic
disorder. They develop complications in many organs. And
one of the most deadly complications is heart disease. We’re
particularly interested in why people with diabetes suffer
from unusually severe forms of heart disease.”
For reasons not fully understood, people with diabetes
are more likely to develop blockages in arteries. After a heart
attack, the course of the subsequent heart disease is more
“Diabetes is an incredibly
aggressive than in people with- common problem that
out diabetes. Even independent
affects a huge swath of
of blocked arteries, there is
evidence that their hearts do
the population. We’re
not function like those of
particularly interested in
individuals without diabetes.
According to the Centers for why people with diabetes
Disease Control and Prevention, suffer from unusually severe
almost 26 million Americans
forms of heart disease.”
are living with type 2 diabetes
J E A N E . S C H AFFE R , M D
and another 79 million with
undiagnosed diabetes or
pre-diabetes, a condition that increases their risk of developing the full-blown variety. With such statistics, it is becoming increasingly important to explore the reasons behind
the aggressive progress of cardiovascular disease in patients
whose bodies do not properly regulate blood sugar.
Schaffer and her colleagues suspect a likely culprit is
abnormal lipid metabolism. Lipids are a class of molecules
that includes fats, such as fatty acids and triglycerides. Past
studies have shown that patients with diabetes store higher
levels of these lipids in their heart muscle, likely impairing
cardiac function. These lipids appear to lead to inflammation
and can also damage important parts of heart cells, such as
proteins and DNA, leading to heart muscle dysfunction. The
goal of the new research program is to identify better measures of heart disease in patients with diabetes.
Washington University will serve as the coordinating
center among five institutions chosen to receive this funding
from the National Institutes of Health (NIH). The other participating centers are the Cleveland Clinic, Emory University,
National Jewish Health and Weill Cornell Medical College.
NIH P20 HL113444
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Global health Henish A.
Bhansali, MD, instructor in medicine,
Victor G. Davila-Roman, MD, professor
of medicine, and Yeshey Penjore, MD, a
cardiologist from the National Referral
Hospital in Thimpu, Bhutan, review a
heart echocardiogram. Penjore trained
at the School of Medicine for two months
as part of the Global Health Scholars
in Medicine Program, a Department of
Medicine initiative designed to expand
global health education. Penjore also
attended continuing medical education
courses and worked alongside Washington
University cardiologists, experiences he
will use to better diagnose and treat his
patients in Bhutan, where there is a high
prevalence of congenital heart disease.

GASTROENTEROLOGY

W

hat happens the day before
a colonoscopy may be just as
important as the test itself.
Gastroenterologists at the School of
Medicine have found that when patients don’t
adequately prep for the test by cleansing their
colons, doctors often can’t see potentially
dangerous pre-cancerous lesions.
Reporting in the journal Gastrointestinal
Endoscopy, the researchers say that doctors
often missed at least one pre-cancerous
growth in about one-third of patients who
did not properly prepare for their colonoscopy.
Polyps and other markers of cancer risk were
then discovered in subsequent colonoscopies.
Although several studies have found that
up to a quarter of colonoscopy patients don’t
prepare adequately for the test, the new
study is the first to point out the potential
consequences of poor bowel preparation in
outpatients at average risk.
“Because so many of the patients had a
follow-up screening less than a year after the
initial test, we strongly suspect that most of
the pre-cancerous growths found during the
outlook.wustl.edu

second colonoscopy already were present at
the time of the initial test,” says first author
Reena Chokshi, MD, a gastroenterology fellow
at Washington University.
Researchers say their findings suggest that
if a physician is having difficulty seeing the
colon due to inadequate bowel prep, the colonoscopy should be stopped and rescheduled.
“Rather than subjecting a patient to the
potential risks of a full colonoscopy when we
may not be able to detect polyps, or other
pre-cancerous growths called adenomas, it
may be better to bring that patient back as
soon as possible for a repeat procedure with
better bowel preparation,” says Chokshi.
On the day before a colonoscopy exam,
people are asked to stop eating solid food and
to consume only clear liquids. Later in the day
and the next morning, patients drink bowelcleansing mixtures to empty the colon prior
to the examination.
The test itself usually takes less than an
hour, and patients are sedated during that
time. Using a tiny camera, doctors are able to
look at the walls of the colon in an attempt

REENA CHOKSHI, MD

Poor colonscopy prep hides polyps

Doctors discover a polyp during a repeat colonoscopy
conducted on a study patient who had not prepared
adequately for the initial exam.
to detect polyps and other pre-cancerous
growths. Once detected, those growths can
be removed during the procedure.
“It generally takes several years for an
adenoma to become cancerous,” Chokshi says.
“So it certainly is possible that any lesion we
miss during a colonoscopy could develop into
a malignancy before a person’s next colonoscopy, especially if it doesn’t happen until
10 years later.”
Outlook 5
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Largest-ever share of cancer
genome data released

Research rewarded Morton E. Smith, MD, councilor
for the Washington University chapter of Alpha Omega Alpha (AOA),
congratulates first-year medical student Gregory C. Ebersole, the 2012
recipient of the AOA’s Carolyn L. Kuckein Student Research Fellowship.
Ebersole is studying the responsiveness and validity of a postsurgical
functional assessment survey for cubital tunnel syndrome, a condition
brought on by increased pressure on the ulnar nerve at the elbow.

Siteman welcomes Komen funding
With more than $5 million in new grants from Susan G.
Komen for the Cure, Washington University scientists at the
Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and
Washington University School of Medicine are developing
innovative treatments in the fight against breast cancer.
The largest portion — $4 million — will be used to better identify which women with estrogen receptor-positive
(ER-positive) breast cancer, the most common form of the
disease, are at highest risk for recurrence and to determine
more effective treatments for those individuals.
“There are so many new drugs out there for breast cancer
patients that we need a way to establish which ones are most
likely to be the home run,” says
Matthew J. Ellis, MD, PhD, professor
A new test under developof medicine and chief of the breast
ment will predict breast
oncology section. “Our goal is to
cancer recurrence and
screen drugs to find the one that
also protect women from
will produce the best outcome for
unnecessary treatment
the patient with the least toxicity.”
and follow-up visits.
Ellis is a co-recipient of the
grant along with Elaine R. Mardis,
PhD, co-director of The Genome Institute at the School of
Medicine, and Pascal Meier, PhD, of The Institute of Cancer
Research in London.
Using DNA sequencing to compare a patient’s normal
and cancerous cells, the researchers are learning why traditional anti-hormone drugs often are only partially effective
in reducing tumor growth. The study involves developing a
test to predict which patients are most likely to experience
recurrence after five years and determining which combination of drugs now in development will kill all ER-positive
cancer cells and prevent recurrence.
6 Washington University School of Medicine

To speed progress against cancer and other diseases, the
St. Jude Children’s Research Hospital-Washington University
Pediatric Cancer Genome Project has announced the largest
release to date of comprehensive human cancer genome data
for free access by the global scientific community.
The amount of information released more than doubles
the volume of high-coverage, whole-genome data currently
available from all human genome sources combined. This
information is valuable not just to cancer researchers, but
also to scientists studying almost any disease.
The release of this data was announced as a part of a
perspective published online May 29 in Nature Genetics.
The 520 genome sequences
released are matched sets
of normal and tumor tissue
samples from 260 pediatric cancer patients. The St. Jude and
Washington University researchers are analyzing the genomic
sequences to determine the differences between each child’s
normal and cancerous cells to
pinpoint the causes of more than
a half-dozen of the most deadly
childhood cancers, an effort
which has already produced
a number of key discoveries
reported in top scientific journals.
Launched in early 2010, the Pediatric Cancer Genome
Project is the world’s largest effort and investment to date
to understand the genetic origins of childhood cancers.
The three-year project will cost an estimated $65 million.
St. Jude is covering $55 million of the cost, including a $20
million commitment from Kay Jewelers, a long-standing
partner of St. Jude. This is the first major privately funded
human genome sequencing project to share its data as soon
as it becomes available.
“This approach has been more valuable than anyone could
have predicted,” says Richard K. Wilson, PhD, director of
The Genome Institute. “We have identified unusual, ‘cryptic’
changes in many patients’ cancer cells that we would not
have found using other methods. We are pleased to be able
to share this data with the research community in hopes
that others can build upon our initial discoveries.”
more information

pediatriccancergenomeproject.org
Autumn 2012

WATERWORLD
Take a look inside a
splashy research facility
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A

common type of minnow, the zebrafish is
increasingly popular in scientific research.

Because its tiny embryos are transparent and
develop outside the body, zebrafish are useful for
observing growth and development. In addition,
while less expensive than mice, research results
from studying zebrafish have been shown to be
just as valuable as those from mice.
Washington University is home to one of
the largest zebrafish facilities in the world. And
with robotic feeding and cleaning systems, it is
the world’s most modern, says Lilianna SolnicaKrezel, PhD, professor and head of the Department
of Developmental Biology at the School of Medicine.

Infertile eggs are extracted
using a stereomicroscope.

“This facility allows us to do large-scale,
collaborative projects that would not be possible for
individual investigators.”
The work of more
than 30 researchers is
currently supported
by the facility. Beyond
sheer numbers of
fish, other resources
Fish larvae beginning their life cycles
abound, such as capabilities for obtaining, viewing and manipulating fish
embryos and calling on the expertise of colleagues
who can help in evaluating experiments.
zebrafish.wustl.edu
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Zebrafish develop rapidly; at 36 hours,
an embryo has a complete body with
most organs and a beating heart.

Fertilized eggs
filter through a
false-bottomed
mating cage, which
prevents the fish
from eating the
eggs and facilitates
embryo collection.

Autumn 2012

Systems automate water,
temperature and more. Each
room has its own centralized
life support, including an
innovative filtration system that passes
used water through a biological filter
(below) before reuse. Alarms can alert
responders to a systems failure.

ROBERT BOSTON

Large numbers of fish grow quickly as robotic feeding machines
travel to each tank, providing frequent small meals.

Fish
capacity
Fish
tanks
outlook.wustl.edu

200,000
6,780

Current
occupancy

Total water
capacity, in liters

80,000
17,898
Outlook 9

It’s for the kids
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Advances in pediatric care are no longer enough.
Today researchers are focused on an even higher goal
— discovering cures for the most serious disorders of
childhood. The Children’s Discovery Institute, a joint
initiative of Washington University School of Medicine
and St. Louis Children’s Hospital, is designed to change
the way pediatric research is conducted. childrensdiscovery.org
By funding innovative research and translating discovery
into treatment, Institute investigators hope to make
significant advances in caring for sick children.
Since its launch in 2006, the Children’s Discovery

Institute has awarded nearly $29.5 million to researchers
tackling deadly pediatric diseases ranging from cancer to
malaria. The targeted effort has united clinicians and investigators from all corners of Washington University, reaching
across 16 departments in three schools.
“In seeking new answers to questions about pediatric
disease, we need to collaborate and think in bold new ways,”
says Mary C. Dinauer, MD, PhD, scientific director of the
Children’s Discovery Institute and professor of pediatrics
and of pathology and immunology at the School of Medicine.
Institute-funded projects in four areas — childhood cancer, musculoskeletal and metabolic diseases, pulmonary disease and congenital heart disease — are “discovery research,”
preliminary studies that may eventually yield new treatments.
“The Children’s Discovery Institute is an interesting concept developed to fund early-stage research that will lead to
a better understanding of childhood disease and treatment,
and in some cases, even prevention,” says Dinauer, who also

serves as the Fred M. Saigh Distinguished Chair in Pediatric
Research at St. Louis Children’s Hospital.
Of the 92 grants awarded to researchers since the
Institute’s inception, 55 percent were to researchers outside
the Department of Pediatrics. According to Dinauer, that’s
unique among children’s disease research.
“We want these grants to bring people from multiple
disciplines together to study in this research area,” she says.
“Other institutions have in-house funding for research, but
it stays within the department.”
The Children’s Discovery Institute also funds a Faculty
Scholars Award that provides three years of support to junior
faculty, allowing them to set up their laboratories, as well
as a summer research opportunities program for undergraduate students.
“In the end, we want to establish new areas of pediatric
research,” Dinauer says. “Creative collaborations will allow
us to conduct outstanding investigations that otherwise
wouldn’t have been possible.”

BY BETH MILLER
outlook.wustl.edu
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The Translational Cardiovascular Tissue Core established by
Jeanne M. Nerbonne, PhD, and colleagues allows scientists to
study hypertrophic cardiomyopathy from all angles.

Understanding a silent danger

A

healthy teenager suddenly collapses during
soccer practice and dies. After his death,
physicians find he was harboring a silent killer
known as hypertrophic cardiomyopathy, a condition in which the heart muscle becomes thickened,
making it harder to pump blood out of the heart.
The condition generally has no symptoms, but
it is the most common killer of adolescents who
are otherwise healthy and is the leading reason for
heart transplants in children.
Despite its prevalence, very little is
known about the genetic
and molecular makeup
or the electrical phenotypes of the hearts of
children with hypertrophic cardiomyopathy. New research funded by the
Children’s Discovery Institute may change that.
Jeanne M. Nerbonne, PhD, the Alumni
Endowed Professor of Molecular Biology and
Pharmacology in Developmental Biology, and
her colleagues received a large initiative grant
from the Institute to develop the Translational
Cardiovascular Tissue Core, a centralized system
for acquiring, banking, annotating with clinical
data, and distributing tissue from diseased hearts.

There is no way to predict
when a seemingly healthy
adolescent might experience
sudden and fatal heart failure.

12 Washington University School of Medicine

It is directed by Kathryn A. Yamada, PhD, professor
of medicine in the Cardiovascular Division.
“As individuals develop heart failure,” says
Nerbonne, “we do not know how to predict who
is going to have the fatal sudden death incident.
It has become increasingly clear that detailed
electrophysiological and molecular analyses of
diseased and non-diseased human hearts are
urgently needed to advance the field.”
Nerbonne, professor of medicine, and her team
take tissue samples from the diseased hearts of
children at the time they get a ventricular-assist
device, which helps the heart pump blood and
is often used as a bridge to a heart transplant.
Investigators then perform various studies on
these tissues, looking at the proteins, RNA, cellular and whole tissue physiology, as well as bank
tissue for genetic and epigenetic analyses. They
also collect diseased hearts at the time of transplant and perform similar studies, comparing
what they find with non-diseased heart tissue.
Notably, the banked tissue and associated data
will be available to all Washington University
investigators for further types of analysis.
“As the science moves forward,” Nerbonne says,
“other researchers will be able to take a different
look at the data for new discoveries.”
Autumn 2012

New therapies under investigation by Audrey R. Odom,
MD, PhD, could stem the threat of malaria, spread by
mosquitoes to millions of children worldwide every year.

Swatting malaria more effectively

I

nternationally, there are 250 million to 350
million cases of malaria each year, resulting in
about 1 million deaths. Most of those deaths are
children under age 5.
Audrey R. Odom, MD, PhD, wants to cure
malaria. The pediatric infectious disease specialist
has been working toward that goal since she came
to the School of Medicine in 2008 with a Children’s
Discovery Institute Faculty Scholars Award.
Odom’s background in cell signaling in eukaryotic organisms, or
microbes that have a
nucleus and organelles like human cells,
led her to apply that
knowledge to a eukaryotic pathogen in child
health. An assistant professor of pediatrics and
of molecular microbiology, Odom says malaria is
hard to control because the parasite has become
resistant to nearly all currently available antimalarial drugs.
“Chloroquine, a mainstay drug for nearly
100 years, is resistant to malaria worldwide,”
Odom says. “Every time we develop a new drug,
we’re going to encounter resistance, so we need to
establish a continual pipeline of new drugs.”

Malaria is hard to control
because the parasite has
become resistant to current
anti-malarial drugs.

outlook.wustl.edu

With funding from a separate grant from the
Children’s Discovery Institute, Odom has made
progress with that pipeline. She has identified a
metabolic pathway that is present in the malaria
parasite and is required for it to grow, but that is
not present in humans.
“In theory, we can create a safe antimalarial
drug,” she says. “What makes this pathway even
more exciting is that it’s also present in the mycobacteria that cause tuberculosis, and there’s also a
real need for new drugs for TB.”
Odom and her colleagues are testing new compounds to see if they inhibit the enzyme and kill
the malaria parasite. Her research team also is
screening a large number of existing compounds
to determine if they have any effect.
But that’s not her ultimate goal.
“I want to identify a small molecule inhibitor
that we can pitch to pharmaceutical companies to
treat bacterial infections in the United States and
that they can then give away to treat malaria and
TB in the developing world,” Odom says.
But the malaria parasite also likely will become
resistant to that drug, she says, so her strategy is to
pair it with another compound.
“Combination therapy,” Odom says, “will be
the way forward.”
Outlook 13
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Researchers Joshua B. Rubin, MD, PhD, and Jeffrey R.
Leonard, MD, use the data bank they created to study
treatment of pediatric brain tumors.

Banking on a store of knowledge

C

ancer is the leading cause of death by disease
among U.S. children between infancy and
age 15. Among major childhood cancers, leukemia and brain and other central nervous system
tumors make up more than half of new cases.
A child with leukemia — a cancer of the
blood cells — has a 90 percent chance of longterm survival. But only two of three children
with a malignant brain or central nervous system
tumor will live beyond five years.
According to researchers
Jeffrey R. Leonard, MD, and
Joshua B. Rubin, MD, PhD,
that needs to change.
Part of the reason
pediatric brain tumors are
so deadly is the lack of samples on which to do research. With funding from
the Children’s Discovery Institute, Leonard, associate professor of neurosurgery and of pediatrics,
and Rubin, associate professor of pediatrics, of
neurology and of neurobiology, have developed a
pediatric brain tumor data bank. It contains tissue
samples from brain tumors in children they have
treated, along with individual patient data such as
age, sex, type of tumor and type of treatment. New
data is automatically entered into the databank.

Brain tumor treatments —
while effective — can
cause brain damage and
other toxic side effects.
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Leonard and Rubin implant the brain tumor
samples into mouse brains. By studying how the
tumors grow in the mice, they can screen thousands of existing compounds to determine if
any work to slow the tumor’s growth or eliminate
the tumor.
Rubin says that current treatments can be effective, but they also can cause long-term damage to
children’s brains. “So,” he says, “even when tumors
are cured, we are still looking for new treatments
with less toxicity.”
Data from the tumor bank also is available to
other researchers to study brain tumors, perform
genetic screens or test for new drugs.
“We have a large number of resources here,”
Leonard says. “We want people around the country to view Washington University as the place to
come for pediatric and adult brain tumor research.
The Children’s Discovery Institute provides a
unique mechanism to support innovative ideas
and collaborative efforts among departments and
across campuses, Rubin says.
“What’s smart about setting it up that way is
it requires people to come up with a novel, collaborative approach to pediatric disease,” he says.
“That prompts research that might not have
happened without support from the Institute.”
Autumn 2012

Thomas W. Ferkol, MD, and a team of diverse researchers
from across the university are studying persistent respiratory,
sinus and ear infections in children.

Linking rare and common diseases

P

ainful middle ear infections are among the
most common infections seen in toddlers
and young children. Many children find relief in
a course of antibiotics, but others experience
recurrent ear infections.
To find answers to what causes these and other
pediatric respiratory infections, the Children’s
Discovery Institute awarded a large initiative grant
to Thomas W. Ferkol, MD, the Alexis Hartmann,
MD, Professor in Pediatrics. Ferkol, also professor
of cell biology and physiology, is a world-renowned
expert on primary ciliary
dyskinesia (PCD), a rare,
inherited lung disease that
results in chronic infections
of the respiratory tract.
He and his team are studying the functional,
structural and genetic characteristics of cilia diseases in children using a single-celled algae model
that is structurally identical to a human cilium.
Ultimately, they will learn more about common
childhood diseases that could lead to better care,
prevention and identification of new treatments.
The cilia are tiny, hair-like structures in the
lungs, nose, sinuses and ears that help clear out
mucus, foreign particles, fluids and bacteria.

Though treatable, ear
infections and other
respiratory infections have
a high rate of recurrence.
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When the cilia don’t function correctly, children
develop respiratory, sinus and ear infections.
In PCD, which occurs in about one in every
12,000 to 20,000 births, cilia are unable to clear
out bacteria-filled mucus from the lungs, sinuses
and ears, resulting in persistent infections. Ferkol
and the research team suspect a link between common ear infections and the relatively rare PCD.
“Children who get chronic ear infections,
requiring repeated treatment with antibiotics and
sometimes surgeries, also may have genetic and
functional defects of the cilia, similar to children
with PCD, but much less severe,” he says.
The team has found genetic mutations that may
impact cilia and flagella, another hair-like structure that functions much like cilia. The mutations
disrupt the biochemical pathways of motor proteins that surround each cilium and make it move.
“Our goal is to connect specific abnormalities
of cilia motion with a child’s genetic profile, then
connect that with a child’s disease,” Ferkol says.
“One day, we could potentially personalize treatment to the genetics and cilia motion abnormalities present in each child.”
Ferkol says the collaboration and support
from the Children’s Discovery Institute have been
instrumental in bringing about these insights.
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Advocating a systems view of musculoskeletal health: Roberto Civitelli, MD,
and Linda J. Sandell, PhD
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The focus of bone health has long been repair.
Broken bones, torn ligaments and damaged cartilage either can be put in a cast to heal or surgically
repaired to restore normal function. Or, a worn
joint can be totally replaced. But that only fixes
the mechanical breakdown. It doesn’t address the
underlying problems that led to the breakdown of
bones, muscles, tendons, ligaments and cartilage.
“If you’re going to have biological solutions,”
says Linda J. Sandell, PhD, the Mildred B. Simon
Research Professor of Orthopaedic Surgery and
professor of cell biology and physiology, “you need
to reach back from the structure to the things that
are performing the function.”

outlook.wustl.edu

“Exactly,” echoes Roberto Civitelli, MD, the
Sydney M. and Stella H. Schoenberg Professor of
Medicine and chief of the Division of Bone and
Mineral Diseases. “We must cover the spectrum,
from the basic biology to cell biology to the signals
between cells that regulate breakdown and healing.
It is much cheaper to prevent problems such as
fractures than to treat them after they occur.”
At the new Washington University Center for
Musculoskeletal Research, researchers are attempting to do just that. By employing a collaborative
approach, they hope to better understand the
biological underpinnings of problems with bones
and connective tissue. C O N T I N U E D O N P A G E 2 0 »

Outlook 17

Core
concepts

Musculoskeletal hotspots
Daily stress makes these areas trouble-prone.
Healthy eating and staying active will
maintain the skeleton. But in some cases,
targeted drug therapies may forestall disease,
prevent fractures and limit the need for costly
joint replacements.

U

N L I K E A P I E C E OF
C HA L K , bone is no dry,
static thing wearing away
with use. A structure at rest, a
machine in motion, the living
skeleton renews itself in cycles,
regulating and interacting with
tissues and systems throughout the
body. Musculoskeletal performance
peaks in adulthood and then
declines, a precursor to pain,
disease and fractures.

At the Musculoskeletal Research
Center, collaborative teams strive to
understand the complex foundations
of bone, joint and muscle health.
These findings will be applied to
osteoporosis, osteoarthritis and
other musculoskeletal conditions.
Earlier detection and treatment — or finding the
means to avoid disease
altogether — will help
to ensure a skeleton’s
long and active life.

Balancing act

osteoporosis

A body tears down and rebuilds
its skeleton every 10 years or so.
This natural cycle is key to
skeletal health — that is, as long
25% 40% as the resorption and formation
processes remain balanced.
RISK
Once bone formation slows later
Age 50+
in adulthood, however, excess
resorption can weaken bones,
increasing the risk of fractures.
Drug therapies that rebalance
the cycle can mitigate the disease
known as osteoporosis.

Excess resorption
leads to osteoporosis

Healthy bone equalizes
resorption and formation

RESORPTION

FORMATION

Osteoclasts
break down
bone tissue

Osteoblasts
build up
bone tissue

Painful legacy

osteoarthritis

Why doesn’t everyone get
osteoarthritis (OA)? The disease
affects skeletal joints and
cartilage, the “cushion” between
50% 50% the bones. Research shows that
some animals inherit the ability
RISK
to repair damaged cartilage.
Age 50+
Understanding and possibly
enhancing this repair process
in humans is one goal of
OA research.
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And the way the space is designed —
“The skeleton and its components
with open labs and open administrative
are part of the organism,” says Civitelli,
suites — it’s natural to bump into one
professor of orthopaedic surgery and
of cell biology and physiology and the
another on a daily basis, which we
leader of an NIH-funded training probelieve will spur new collaborations
gram in skeletal disorders. “Without
across disciplines and foster creativity
the skeleton, you don’t have any way for
within the research base.”
muscles to function. You would have no
Other key members of the center
protection of soft tissues, and you would
include associate directors Matthew J.
have no way of regulating many key
Silva, PhD, and Steven L. Teitelbaum,
cellular processes. We’re even learning
MD. Deborah V. Novack, MD, PhD,
that bone is necessary for normal
directs a core devoted to microscopic
glucose metabolism.”
and molecular analysis of bone, muscle,
“Roberto’s point is that the bone is
cartilage, tendons and ligaments, while
doing more than just taking care of
David M. Ornitz, MD, PhD, and Fanxin
itself,” Sandell adds. “We’ve got cells
Long, PhD, lead a mouse genetic core.
that make bone and cells that resorb
One of the center’s investigators
Intricate computer scans offer inside views
bone, the so-called osteoblasts and
produces mice with genetic traits that
of bone and joint health in animal models.
osteoclasts. Those regulate the bone,
mimic various bone and connective
but the bone appears to be regulating
tissue diseases, while other researchers
other things. There are clear connecare developing animal models to find
tions between diabetes and obesity and inflammation and
better ways to regenerate bone, cartilage and muscle.
the skeleton. That’s why we need all of these investigators
Ultimately, all of the studies will provide not only a better
working together. One specialty just doesn’t bring enough
understanding of the biology of skeletal problems, but more
to the table to understand this anymore.”
insight into multiple disorders and how they interact. But it
The Center for Musculoskeletal Research, a joint effort
all starts with individual investigations.
primarily involving investigators from the Department of
Civitelli’s primary research focus is osteoporosis. As with
Orthopaedic Surgery and the Department of Medicine’s
other problems, he says it once was true that many cases of
Division of Bone and Mineral Diseases, is located in the
osteoporosis were discovered only after a fracture. Now it’s
BJC Institute of Health at Washington University School of
possible to screen for weakening of bones long before they
Medicine. In all, the center includes investigators from 54
break. Doctors can use a machine called a DXA scanner
laboratories. Not all of those laboratories are housed in the
(Dual-energy X-ray Absorptiometry) to measure bone minnew space, and not all of those investigators work mainly
eral density and determine who is at risk for fractures. The
with the muscles of the skeleton, but all are contributing in
center also has a small DXA scanner and other more sensitive
some way to an interdisciplinary effort to better understand
techniques to study bone structure and strength in mice. By
the biologic causes that underlie skeletal problems.
studying how bone cells work, investigators are developing
“We have a historic interaction because most of us used to
new approaches by which weak bones can be made stronger.
be housed in the Yalem Research Building,” says Sandell, who
Sandell focuses on osteoarthritis. For the most part, early
directs the NIH-funded program that supports the center’s
diagnosis of osteoarthritis isn’t yet possible. Patients don’t go
to the doctor until they’re already having pain and stiffness.
core activities. “We had collaborations between investigators
But there are some known risk groups.
that allowed us to put together a center grant, and that greatly
“Half a million people have arthroscopic knee surgery
facilitated the creation of a center on this floor. Now we hope
each year to treat torn meniscus cartilage,” she says. “When
to launch a number of major projects that will help us diagthose injuries occur in young people, they’re likely to
nose and treat bone and connective tissue problems earlier
develop arthritis later in life. So we have to find some way to
so that we can prevent more serious problems later on.”
repair these injuries, other than just treating the structural
Like other floors in the Institute, workspace in the new
problem in the knee with surgery. We need to understand
musculoskeletal center is organized with cores in the center
and laboratories surrounding those cores. Investigators’
what’s going to happen to that person 10 or 20 years later.”
offices line a hallway along the north side of the building.
That expanded understanding is the center’s reason for
It’s designed, says Civitelli, so that investigators in the
existence. Although not all associated investigators are
center will see each other… a lot. “All of this didn’t just come
pulling in a single direction, working together will allow
out of the blue,” he explains. “This is the end of a long process
the researchers to better understand what goes wrong
of nurturing trainees, attracting investigators to this field,
not only in osteoporosis and osteoarthritis, but in other
and building infrastructure.
musculoskeletal problems.
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A tree-lined dirt
road leads to a
new hospital for
African women.

Serving a Need
An unspeakable problem. An underserved population.
An undeterred physician who championed their cause.
BY DIANE DUKE WILLIAMS
outlook.wustl.edu
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or L. Lewis Wall, MD, a dream has come true.
For almost 20 years, he worked doggedly to build a
hospital in one of the world’s poorest countries to treat
women with a devastating childbirth injury. His dream
became reality this past February, when the 42-bed Danja
Fistula Center opened in Niger, a landlocked, arid country
in West Africa. The facility is dedicated to repairing obstetric
fistulas, childbirth injuries that result from untreated prolonged labor, which leave women — and often girls —
with a complex mixture of medical and social problems.
“It was wonderful to be there that day,” says Wall,
professor of obstetrics and gynecology and of anthropology.
“This hospital may seem small by American standards, but
it will make a huge difference in the lives of so many women
who have suffered needlessly for too long.”
Obstetric fistulas are holes between body cavities that
open up following severe tissue damage. They occur in
women of all ages but are more common among those
In Niger, the largest nation in West Africa, a serious health problem
went largely untreated until recently. L. Lewis Wall, MD, and his wife,
Helen (far left, above), donned traditional African garb for the opening of the Danja Fistula Center earlier this year. The new facility offers
hope to thousands of women who have suffered severe injury during
childbirth. Accommodations for patients’ families (far right, above)
give them a place to stay during treatment and recovery.
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who marry young and whose narrow pelvises make them
susceptible to childbirth trauma. In developing countries,
where women tend to give birth at home rather than in a
hospital, days of pushing during difficult labor can result
in terrible injuries.
Fistulas can form between the vagina and the urinary
tract or rectum. The result is extremely unpleasant; women
are left steadily leaking urine and sometimes feces. While
the condition can usually be fixed with surgery, a lack of
health care options leaves many who suffer in this way
with no hope of recovery.
To make matters worse, many African women who
develop fistulas are divorced by their husbands, cast out
by their families and must eke out a meager living with no
marketable skills. Often, they are forced to live humiliating,
desolate lives on the edge of their villages.
“When these women get a fistula, life is basically over
for them,” Wall says. “They become social pariahs. With an
inexpensive surgical repair, we are able to give them back
their life and dignity. It’s astonishing.”
Lewis first encountered the problem of fistulas while
working as an anthropologist in northern Nigeria on a
Fulbright-Hays fellowship. Eventually, he decided the world
needed doctors more than it needed anthropologists. After
graduating from medical school, he became fascinated by
urogynecology, a subspecialty that treats women who have
urinary or fecal incontinence and prolapse of the vagina,
bladder or uterus.
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In 1995, after visiting a large fistula hospital in Ethiopia,
Wall envisioned opening a similar facility in West Africa,
where fistulas are prevalent.
He founded the nonprofit Worldwide Fistula Fund to
raise money to construct hospitals to repair fistulas. The
fund has helped support and build a number of fistula
centers in Africa. It also has provided money to train local
doctors to perform the surgical procedure and to help raise
awareness of the problem.

Mark J. Manary, MD, the Helene B. Roberson Professor
of Pediatrics, understands some of the obstacles Wall faced
in getting the hospital built. Over the past 15 years, Manary
has spent a great deal of time in Africa, where he developed
Project Peanut Butter, a non-profit organization that produces
a peanut-butter mixture to treat children with malnutrition.
“Lewis’ work removes a huge burden, a permanent scar,
from the lives of thousands of African women,” Manary says.
“I admire his commitment and persistence.”

In Niger, among the scattered grasslands on the edge of the

Each year, about 1,000 women will have fistula surgery in
the new facility, which is affiliated with an existing leprosy
hospital run by a Christian missionary organization. Some
will travel hundreds of miles by truck or bus to get there.
Aside from repairing fistulas, the hospital will oversee
outreach efforts to promote maternal health and reduce
childbirth deaths. It also will educate women about microfinance to teach them about business and empowerment.
The new hospital is part of a grand vision to eradicate
fistulas worldwide by building fistula centers that will serve
as focal points for maternity care and public health outreach
in the world’s poorest countries.
“For starters, we hope this hospital will help countless
women and alleviate human suffering,” Wall says. “We also
hope it will advance women’s rights and gender equality.
There still is a lot of work to do. But for now, I’m just going
to enjoy this accomplishment.”

Saharan desert, people grow millet and raise sheep, cattle
and goats. The majority of people live on less than $1 a day.
There are very few personal or private resources for medical
clinics or hospitals, so getting the Danja Fistula Center built
was much more difficult than Wall originally anticipated.
“I thought I was fairly realistic because I had lived in West
Africa for two years,” he says. “But we had to contend with
unexpected obstacles — bureaucratic hassles, insects, a lack
of communication and supplies, and people who thought
their own interests would be threatened by such a facility.”
He also had to raise about $1 million.
Large contributions from the Trio Foundation of
St. Louis, South African musician Dave Matthews and an
executive at Merrill Lynch helped the Worldwide Fistula
Fund reach its goal. The fund also received many small personal donations, including $35 from a potluck hosted by a
group of elderly women in New York.
“This was not my individual achievement,” says Wall.
“It was a result of the efforts of thousands of people.”
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Matthew R. MacEwan is no ordinary medical student. The neurosurgeon-to-be,
a student at the School of Medicine, also is pursuing a doctorate in biomedical
engineering at Washington University. And, at 29, he recently started his own
local company, Retectix LLC, aimed at revolutionizing the surgical mesh used
in operating rooms worldwide.
The company’s lead product, invented by MacEwan and Jingwei Xie, PhD,
a former postdoctoral researcher in engineering, is a synthetic polymer mesh
made of synthetic nanofibers. The mesh was developed to repair defects in the
membrane surrounding the brain and spinal cord, but also could be used to
mend tissues as well. The nanofiber material has the potential to make operations
easier for surgeons and reduce the rate of complications experienced by patients.
Existing surgical mesh used to repair the protective membrane

that covers the brain and spinal cord is thick and stiff, making
it difficult to work with. But the novel material MacEwan and
Xie developed is thin and flexible and more easily integrated
into the body’s own tissues.
“It’s almost like a cloth,” MacEwan says. “But it’s designed
on a nanoscopic scale. To put that into perspective, every
thread of the mesh is hundreds to thousands of times smaller
than the diameter of a single human cell.”
The technology’s promise has caught the attention of
the business world. In 2011, MacEwan won the Olin Cup,
sponsored by Washington University’s Skandalaris Center
for Entrepreneurial Studies. In June he won the Licensing
Executives Society Foundation’s International Graduate
Student competition in London, and last November, the
Idea to Product Global Competition in Stockholm. The
winnings of more than $100,000, along with other investments and in-kind services, have helped MacEwan get the
company off the ground.
The nanofiber material developed by MacEwan and
Xie, now a senior scientist at Marshall University in West
Virginia, along with collaborators Younan Xia, PhD, the
James M. McKelvey Professor of Biomedical Engineering,
and Zack Ray, MD, now an attending neurosurgeon at the
School of Medicine. MacEwan has worked closely with
Washington University’s Office of Technology Management,
which has filed patents on the technology.
“We’ve taken the whole idea of surgical mesh and pushed
it into a new direction,” MacEwan says. “It’s not just a foreign
material you’re putting into the body. The nanofabricated
nature of the mesh creates a scaffold that cells can easily
penetrate and populate to recapitulate the body’s tissues.”
outlook.wustl.edu
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A student’s “big” vision will help surgeons and patients alike

Co-inventor of promising nanofiber:
Matthew R. MacEwan

The surgical mesh looks like gauze but feels sticky, like
a spider web. It is typically composed of multiple layers of
nanofibers and can be cut to size for different uses. Once the
mesh is placed in the body, cells grow along the individual
nanofibers, which gradually degrade in nine to 12 months,
leaving only the body’s own tissue in their place.
One advantage of the new technology is that different pat-

terns of nanofibers can be created in the mesh to promote
the healing of different kinds of wounds. For example, in
a starburst pattern used to repair ulcers and other circular
wounds, the nanofibers originate from a central point and
radiate outward. This encourages cells to migrate and grow
toward the center of the wound. For linear defects like tears
and incisions, nanofibers can be aligned perpendicular to
the wound, encouraging cell growth across the injury, which
provides reinforcement to the new tissues.
MacEwan is currently evaluating the product in animal
models, a first step toward gaining U.S. Food and Drug
Administration approval. Preliminary studies indicate the
nanofiber material is safe and effective; MacEwan is hopeful
that clinical trials in patients will begin later this year.
For now, MacEwan is finishing his doctorate and has two
years left before he receives his medical degree. He’s planning a career in academic medicine, where he can spend
time in the laboratory and the operating room. There, he
hopes to use the nanofiber surgical meshes he developed to
improve the care and surgical outcomes of his own patients.
“At Washington University, I have continually focused
on moving discoveries beyond the laboratory,” MacEwan
says. “I hope to see this technology have a positive impact
on many patients. Nothing would be more thrilling.”
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mentor memorial funds

BY STEPHANIE STEMMLER

Leaving their marks
Diverse physicians honored with lasting legacies for education

Four distinguished former
faculty honorees, left to right:
Walter F. Ballinger, MD, John P.
Boineau, MD, Paul R. Manske, MD,
and J. Neal Middelkamp, MD
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alter F. Ballinger, MD, embodied the spirit of rigorous and
broad-based learning at Washington University School
of Medicine. Former head of the Department of Surgery,
Ballinger relished his role as an educator.
“He thrived on teaching and cared deeply about training the next
generation of surgeons,” says his wife, Mary Randolph Ballinger.
“He always wanted to bring out the excellence in their talents.”
Timothy J. Eberlein, MD, the Bixby Professor and head of the
Department of Surgery says, “Dr. Ballinger often said that training the
next generation of surgeons would be the most important, and among
our most challenging, tasks.”
So it was a fitting tribute that shortly before Ballinger passed away
last year at the age of 85, one of his first surgical interns, Gordon W.
Philpott, MD, suggested a fund that would support the establishment
of the Dr. and Mrs. Walter F. Ballinger Surgical Academic Education
Program. The initial endowment was funded by the Ballingers, and
former residents and friends made generous contributions.
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The program enables the Department of Surgery to expand
the knowledge of surgical training beyond the clinical practice of surgery to include topics such as ethics, public health
and health care delivery.
“This is a way to honor the school and the person and to
benefit society through advancement of education,” says
Philpott, emeritus professor of surgery and a former member
of the university’s Board of Trustees. “It fits with Walter’s
own passion of continuous learning.”
Washington University School of Medicine has received
many gifts to honor faculty who have been outstanding mentors and colleagues. The outpouring of generosity for recent
memorial gifts reflects the school’s collegial spirit.
In the Cardiovascular Division, the first John P. Boineau
Lecture was held in April 2012 to honor Boineau’s contributions in the fields of cardiothoracic surgery and cardiology.
The lecture fund was created through the generosity of
current and former faculty and former residents.
“Dr. Boineau made substantial contributions to the CoxMaze procedure for the treatment of atrial fibrillation, the
most common arrhythmia that we treat,” says Douglas L.
Mann, MD, Lewin Professor and chief of the Cardiovascular
Division. “This procedure formed the basis for ablation
therapy and is practiced by electrophysiologists on a daily
basis. Dr. Boineau’s contributions will continue to be felt for
the next decade, and likely well beyond that.”
In the Department of Orthopaedic Surgery, the Paul
Manske, MD Resident Learning and Teaching Center debuts
next year to honor his memory. Manske, the former chairman of the department, died in April 2011.
“We are dedicating this space in honor of
Dr. Manske because he was a world-renowned
hand surgeon and a true gentleman who also
was a highly effective teacher. This center will
enable us to honor his legacy and his life here
at the medical center where he spent nearly
his entire career,” says Richard H. Gelberman,
MD, the Fred C. Reynolds Professor and head
of the Department of Orthopaedic Surgery.
“It will be a state-of-the-art learning center
for residents and house staff encompassing
individual computer carousels, an anatomical
dissection facility, and an arthroscopy and surgical skills
simulation center.”
Former orthopaedic surgery resident Bruce A. Bollinger,
MD, was among those who made a memorial gift to
recognize Manske. “Dr. Manske was an excellent surgeon, research scientist and educator and was always very
approachable with questions or issues,” says Bollinger.
“I feel I owe much to him and the rest of the faculty during
my time at Barnes, and I hope the new center will facilitate
education and training through easier access to information
and hands-on simulator equipment.”
In November, the Department of Pediatrics will host the

Stuart S. Sagel, MD

11th annual J. Neal and Lois Middelkamp Lecture. The
lectureship rotates topics between Middelkamp’s passions
— infectious diseases and medical education. “The establishment of this lectureship enables us to bring in national
and world leaders to inform and inspire the Washington
University community,” says Alan L. Schwartz, PhD,
MD, the Harriet B. Spoehrer Professor and head of the
Department of Pediatrics. The Middelkamps established the
endowed fund in 2001 and, upon his death in November
2011, gifts in tribute to his accomplishments and mentorship
were directed to the fund. The comments from former students and residents reflect a tremendous depth of gratitude
for the role he played in their lives.

Washington University School of Medicine has
received many gifts to honor faculty who have
been outstanding mentors and colleagues.
The outpouring of generosity for recent memorial
gifts reflects the school’s collegial spirit.
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Another beloved mentor and colleague, Stuart S. Sagel, MD,
will be recognized in the Mallinckrodt Institute of Radiology
with a conference room named in his honor. “Residents, fellows and faculty members alike benefited from his excellence
as a clinician and teacher for decades,” says R. Gilbert Jost,
MD, the Elizabeth E. Mallinckrodt Professor and head of
the Department of Radiology and director of Mallinckrodt
Institute of Radiology. Teaching conferences will be held in
the renovated space and will serve as an ongoing reminder
of Sagel’s many contributions. Sagel passed away in
November 2011, and the Mallinckrodt Institute of Radiology
will keep his legacy alive through this constant reminder.
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distinguished professorship

BY JULIE MAHONEY

An eye for patient care

J

MARK BEAVEN

ohn F. Hardesty, MD, spent his career caring for the needs of

visually impaired children and their families. He dedicated his
life to improving the quality of life for all with whom he came in

contact. It is in his memory that his daughter, Jane Hardesty Poole,
established the John F. Hardesty, M.D. Distinguished Professorship
in Ophthalmology and Visual Sciences. Hardesty’s life and work were
honored on May 31, 2012, at the installation ceremony and lecture of
R. Lawrence Tychsen, MD, the inaugural professorship holder.
Hardesty (1887–1953) was an eminent St. Louis ophthalmologist,
teacher, writer and war hero whose heritage dates to Colonial and
early Missouri settlers. He received bachelor of science and doctor of
medicine degrees simultaneously from Saint Louis University in 1914.

28 Washington University School of Medicine

Following his graduation from medical school, he spent two years as
an intern and later a resident at St. Louis City Hospital.
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Pediatric ophthalmologist R. Lawrence
Tychsen, MD, examines the eyes of
young patient Clark Griffin.

Washington University
Chancellor Mark S. Wrighton,
R. Lawrence Tychsen, MD,
Jane Hardesty Poole and School of
Medicine Dean Larry J. Shapiro, MD.

Hardesty enlisted in the U.S. Army Medical Corps and
was later transferred, at his own request, to the Seaforth
Highlanders in the British Military Service. In this capacity,
he served on the front lines of World War I until March 1918,
when he was captured by the German army and held at
Baden-Baden for eight months as a prisoner of war until the
armistice. He received an honorable discharge as a captain
in March 1919.
Hardesty joined the Saint Louis University School of
Medicine faculty in 1920, advancing to senior instructor
in 1928, assistant professor in 1931, and associate professor
in 1934. He served with distinction in that role until 1953.
During his tenure, he served as acting chair of the school’s
Department of Ophthalmology.
Hardesty’s pioneering 1934 thesis for membership in
the prestigious American Ophthalmological Society was
titled “Treatment of Glaucoma by Systemic Measures.”
Although the first recorded treatments for glaucoma date
to the mid-19th century, Hardesty performed research and
published papers on treating the disease using “systemic”
medication, drugs introduced to the body intravenously or
subcutaneously. This represented the first attempt to treat
glaucoma in systemic form. Hardesty’s idea of using epinephrine to treat glaucoma is still in use today in eyedrop form,
and his work was foundational to the development of the
oral drug Diamox in the 1950s by Bernard Becker, MD, at
Washington University.
Often described as “a gentleman and a scholar,” Hardesty
left among his papers a list entitled “Things I Wish I had
Known Before I was Twenty-One.” The last item noted: “the
greatness of the opportunity and joy of serving a fellow man.”
Nothing guided the life and work of Hardesty more than this.
“My father gave so much of himself to help individuals
from all walks of life to retain their sight,” says Poole, a 1961
graduate of Washington University. “He was very modest
and humble, yet a towering figure. I am so pleased that I can
honor him in this way.”
The inaugural recipient of the Hardesty Professorship,
R. Lawrence Tychsen, MD, graduated from Georgetown
University with majors in biology and philosophy, receiving
his medical degree from Georgetown in 1979. He finished
residency training at the University of Iowa Hospitals in
outlook.wustl.edu

1983, followed by fellowships at the University of California
San Francisco (pediatric and neuro-ophthalmology) and
the Smith-Kettlewell Institute, San Francisco. He also was
a neuroscience research postdoc both at the National Eye
Institute/National Institutes of Health (NIH) and at UCSF.
From 1985 to 1989, Tychsen served in the U.S. Air Force
as a flight surgeon/pediatric ophthalmologist at the School
of Aerospace Medicine and the Wilford Hall Medical Center,
San Antonio.
In 1989, Tychsen joined the Washington University
School of Medicine faculty, where he is professor of ophthalmology and visual sciences in pediatrics and professor of
anatomy and neurobiology. He is ophthalmologist-in-chief at
St. Louis Children’s Hospital.
Tychsen’s clinical work focuses on three topics: surgical
repair of vision in children with ocular and brain damage
(including prematurity, cerebral palsy, Down syndrome and
autism), refractive surgery (excimer laser and intraocular
implants) for children who have major difficulties wearing
eyeglasses or contact lenses, and eye muscle surgery for
children and adults who have crossed eyes (strabismus) and
eye movement abnormalities (nystagmus). He is principal
investigator on NIH R01-funded studies of visual brain
maldevelopment and repair in infant primates, as well as
clinical studies of visuomotor abnormalities in cerebral palsy
and pediatric refractive surgery.
Tychsen has published more than 200 clinical and basic
science journal articles or book chapters. He serves on the
editorial boards of several journals, as well as panels for
national and international ophthalmology associations, the
National Eye Institute of the NIH, the Pediatric Eye Disease
investigator group, and the Food and Drug Administration.
Tychsen has mentored more than 30 undergraduate and
medical students over the course of his teaching career and
has received numerous awards, lectureships and honors.
“It is humbling and inspiring to be named as the first
Hardesty professor,” Tychsen says. “Dr. Hardesty was not
only an accomplished ophthalmologist, but beyond this a
great husband and father, and a brave patriot. He knew that
he had been called to a vocation, not just a profession, and
that he was the instrument of a purpose. I’ll embrace his
spirit in the work of the professorship that his daughter,
Mrs. Poole, has so generously provided.”
Outlook 29

reunion

BY JULIE MAHONEY

MD Class of 1962 begins new Reunion tradition

M

2012 graduate Mark D.
Mangano, MD, visits with
members of the Class of
1962 after receiving his
alumni pin.

30 Washington University School of Medicine

MARK BEAVEN

embers of the Class of 1962 welcomed this
year’s graduates into the medical profession and a unique camaraderie of colleagues with a new Washington University School
of Medicine alumni pin. The pins were presented
at the Alumni Awards Banquet on April 28, 2012,
marking the culmination of a busy Reunion
weekend of activities for alumni and guests.
The idea behind the pin and the beginning of a
new tradition was sparked by conversations with
alumni and Washington University physicians
who have alumni pins from other medical schools.
The pins can be worn on white coats and allow
alumni to subtly display school pride.
The pins also presented an opportunity to
introduce new graduates to the Washington
University Medical Center Alumni Association,
while bridging the 50-year gap that separates
the Golden Anniversary and current graduating
classes. Advancements in medical training, treatments and technology make the experiences of
both groups of physicians very different, but the
common bond of Washington University represented in the alumni pin unites them.
The 50th Class Speaker, William H. Gondring
III, MD, introduced the tradition and announced
that he and his fellow classmates would present

each of the graduates with a pin as a token of
congratulations. The 2012 graduates surrounded
the Class of 1962 and a hush fell over the ballroom. Heartfelt comments and genuine gratitude were expressed by the young physicians to
the senior alumni. It was an intimate moment
between individuals, but its impact was palpable
throughout the entire ballroom.
A general sense of awe and respect for one
another was evident. The new graduates took the
pinning ceremony seriously, with a reverence for
the older alumni that might at first come as a
surprise. But then again, the respect they demonstrated is a natural byproduct of the long years of
training, the unique skill sets required of physicians, and the important regard held for the mentors who guide students through the process of
medical education.
“I remember admiring the Class of 1962 and
especially noting their sense of humor and ease of
interaction with all of us,” reflects 2012 graduate
Tara C. Jackson, MD. “They were encouraging
about our future prospects and careers. I enjoyed
the support and connection we all felt to the
alumni. It was inspirational! They were once in
our shoes and it means the world to see where
they are now.
“Seeing how they kept in touch with their
class at Washington University and maintained
the informal, friendly relationship they had as
students 50 years ago was also priceless,” says
Jackson, “and very encouraging during this
emotional time in our lives.”
According to Gondring, the ceremony
represented more than a transfer of 50 years of
health care commitment from one medical class
to another. “It also represents recognition of
new skill sets obtained by the new graduates as
a continuation of a similar learning experience
obtained by the presenting alumni,” he says.
The pinning ceremony, a huge success, will now
be a featured event at Reunion, and takes its place
alongside long-held School of Medicine traditions
such as the White Coat Ceremony and Match Day.

Interested in seeing more of the people,
events and activities of MD Reunion 2012?
medicine.wustl.edu/reunion/photogalleries
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professorship

BY MICHELE HOEFT

ROBERT BOSTON

A blending of entrepreneurial spirit

Samuel A. Wickline, MD,
the inaugural recipient
of the J. Russell Hornsby
Professorship in
Biomedical Sciences

outlook.wustl.edu

J

ames Russell Hornsby’s company, Cepia Inc.,
was founded on the premise that sufficiently
advanced technology is indistinguishable
from magic. With that in mind, he has created a
world of electronic toys that entertain and delight
children and adults alike.
Chief among the company’s successes are the
popular robotic Zhu Zhu Pets, included on Time
magazine’s “All-TIME 100 Greatest Toys” list.
But Hornsby’s interest in technology doesn’t end
with his devotion to toys; he’s also fascinated
with how technology can spur advancements in
medical research, with a particular focus on
curing cancer and other major diseases.
A former undergraduate parent, his affiliation
and appreciation of Washington University were
already solidified. As an avid supporter of various
community philanthropic organizations, the
St. Louis-based Hornsby expressed interest
in building a relationship with the School of
Medicine that would support medical science and
the groundbreaking achievements of the school’s
physician-scientists.
That determination to give back resulted
in the establishment of the J. Russell Hornsby
Professorship in Biomedical Sciences. This
significant gift will be used to support the work
of the professorship’s inaugural recipient,
Samuel A. Wickline, MD, professor of medicine,
of physics, of cell biology and physiology, and of
biomedical engineering.

A successful entrepreneur in his own right,
Wickline established the Washington University
Consortium for Translational Research in
Advanced Imaging and Nanomedicine, known
as C-TRAIN. Located at the St. Louis CORTEX
Center, C-TRAIN is devoted to diagnostic and
therapeutic development of nanotechnology for
broad-based clinical applications, in conjunction
with corporate and academic partners.
Mirroring Hornsby’s premise, Wickline’s
pioneering nanoparticle research has shown
that truly advanced, groundbreaking technology
can be used to create another type of magic —
changing the way medical diagnoses are made
and improving the safety and efficacy of drug
treatment, thereby benefitting patients.
Imagine being able to replace multiple
medical tests, scans and treatments with a single
injection. That’s the promise offered by nanoparticles, extremely small, bead-shaped units that
can become carriers of medicine. Using these tiny
particles, doctors will be able to locate disease sites
deep within the body and at the same time determine their size, shape and molecular features.
They can then adapt the nanoparticles to deliver
therapeutic drugs exactly where needed and
personalized to each patient.
In addition to his research, Wickline created
the Siteman Center of Cancer Nanotechnology
Excellence at the Alvin J. Siteman Cancer Center
at Barnes-Jewish Hospital and Washington
University School of Medicine. The center is
devoted to nanomedical therapeutics for cancer.
He also established the St. Louis Institute of
Nanomedicine, a consortium of academic and
commercial partners devoted to enhancing
regional infrastructure for the translational
advancement of nanotechnology in medicine.
Hornsby’s entrepreneurial spirit is a perfect
match for Wickline’s research efforts. The
J. Russell Hornsby Professorship in Biomedical
Sciences and Wickline’s development of nanoparticle technology will continue to give hope
that one day we will see the magic and no longer
have to only imagine.
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1930 S
Benjamin Milder, MD 39
Milder published a sixth book of poetry,
From Adolescence to Senescence–A Life in
Light Verse, in 2010.

1940 S
Robert Royce, MD 42
Royce is retired and enjoying life to the
fullest. His interests include golf, bridge,
ecology, and being on the ranch.
George Prothro, MD 45
Prothro enjoys traveling and volunteer
work. He has participated in a program
which makes unused, sealed prescriptions from nursing homes available to
the indigent.
Stanley Wald, MD 46
Wald, though retired, participates in lifelong learning courses and volunteers at
a local grade school.
Theodore Bryan, MD 47
Bryan retired from practice in 1998. His
hobbies include reading and the occasional round of golf. He continues to enjoy
his time with his wife of 62 years, Bertha
“Benny” Benadine.

1950 S
Edgar Draper, MD 53
Draper was the 50 Year & Life Medal and
Distinguished Fellow Award recipient from
the American Psychiatric Association in
May 2011.
J. Roger Nelson, MD 53
Nelson wrote and published a novel, The
God Whom Moses Knew, in August 2010.
Rillah Owen, NU 54
Owen retired in 1997 and has moved to
Lewes DE. She took up watercolor (plein
air painting), volunteers for the risk manager at Beebe Hospital in Lewes, and is
active in swimming, traveling, baking and
playing bridge. Owen belongs to three
art leagues and has gone on a jazz cruise
every year for the past seven years.
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Donald Harkness, MD 58
Harkness is still playing tennis several
times a week. Last June he took his
12-year-old granddaughters to Japan.
He is still helping in a hematology course.

1960 S
John Crane, MD 64
Crane is still working part-time. He is
enjoying life, doing some (non-medical)
writing, traveling and sailing his old
Pearson P-30.
Michael Reif, MD 68
Reif retired from private practice in 2004.
He spent more than six months in North
Carolina’s Blue Ridge Mountains. He has
been married 47 years and has eight
grandchildren.
Penelope Shackelford, MD 68
Shackelford is still restoring land in
Wisconsin and enjoying her grandchildren.
Michael Pacin, MD 69
Pacin has been awarded the Intercultural
Human Rights Award at St. Thomas
University School of Law in recognition
of his commitment to diversity, the fight
against human trafficking, and assistance
to those in need in the community. Pacin,
who is the founder and was the CEO for
35 years of the Florida Center for Allergy &
Asthma Care, expanded his practice from
two to 17 offices and implemented a
policy of “giving back” by providing affordable or free medical care to indigent
patients. He continues to work full time,
caring for patients, administering a large
practice, and serving his community.

1970 S
Bruce Broudy, MD 74
Broudy was elected the 2012 president of
the Lexington Medical Society. He resides
in Lexington KY, where he works in the
area of pulmonary medicine.
Charles Newton, MD 75
Newton is currently a private practice
cardiothoracic surgeon in Huntsville AL.
He celebrated his 30th anniversary as
a surgical subspecialist by retiring the

scalpel on April 15, 2012. In June, Newton
and his wife, Ann, a former scrub nurse
from Brigham and Women’s Hospital in
Boston, moved to Tampa FL, where he
began a palliative medicine fellowship at
University of South Florida. He is excited
with this invitation to redirect his medical
career, enabling him now to devote his
energy and expertise to ameliorating the
suffering of the terminally ill.
Thomas Cooper, MD 76
Cooper and his wife, Linda Loney, MD 76,
are both retired. They recently moved to a
condominium in the south end of Boston
from the suburbs, which they are very
happy about.

1980 S
Linda Douglas, MD 82
Douglas returned to private practice
after 20 years in medical education and
residency education at Rush Medical
College and Medical College of Wisconsin.
She is happy to now have time to concentrate on patients, her kids and life.
Her children, Karen and Daniel, are 25
and 21, respectively.
Gary Chun, MD 84
Chun is trying to be a jazz drummer in
his free time.
John Donovan, MD 87
Donovan has climbed Mt. Kilimanjaro and
participated in five surgical missions in
South America in the past five years. His
hobbies include biking, swimming and
watching his daughters play softball.
Rosalie Hagge, MD 88
Hagge is an associate clinical professor
of radiology and nuclear medicine at
the University of California, Davis
Medical Center.
Robert McMahon, MD 89, HS 92
Robert McMahon, JD, MD, a gastroenterologist, has been elected 2012
president of the St. Louis Metropolitan
Medical Society, the association representing physicians in the St. Louis area.
He is in private practice with St. Louis
Gastroenterology Consultants in south
St. Louis County.

Autumn
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1990 S
Grant Hoekzema, MD 92
Hoekzema is in his 12th year as director
of the Mercy Family Medicine Residency
program and a clinical professor of family medicine at Saint Louis University. His
hobbies include traveling and watching
his children grow and develop career
plans of their own. He was elected president of the Association of Family Medicine
Residency Directors for this coming year.

Let us know what’s new with you.
awards honors news activities & more!

Name _______________________________________________________________
Address ______________________________________________________________
City/State/Zip __________________________________________________________
Specialty _____________________________________________________________

Kristin Kjensrud, PT 92
Kjensrud and her partner have a son,
Nathaniel, 2. She teaches in the physical
therapy assistant program at Mt. Hood
Community College.

Class/HS Year __________________________________________________________

Corina Norrbom, MD 94
Norrbom spent July 2009 through
September 2010 working as a general
practitioner in New Zealand. She found it
to be a wonderful experience, learning a
little and teaching a little every day. This
opportunity to experience another health
system firsthand was invaluable to her.

What’s New ___________________________________________________________

Louis Kuchnir, MD 97
Kuchnir and his wife, Karen, are settled
in the suburbs west of Boston with their
children, who are now in 4th, 7th, 9th and
10th grades. He is now in his 11th year of
owning his private practice.
Dina Levin, HS 97
Levin moved to central Vermont, where
she is an ob/gyn at Gifford Medical Center.
She has two sons.
Richard Tsai, MD 98
Tsai is the medical director and a practicing clinician at Providence Medical Group.

2000 S
Linda Cummings, MD 01
Cummings and her husband enjoy
spending time with their son Matthew,
who is about to turn 2.
Betsy Peterson, MD 02
Peterson is founder and president of
Community Pediatrics, SC in Beaver Dam
WI and Waupun WI. She started a pediatric
clinic in a town east of Madison WI that
had no previous pediatrician. In the past
outlook.wustl.edu
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seven years, it has grown to now have
two pediatricians, two pediatric nurse
practitioners, and two locations with nine
additional employees and more than
3,000 patients. Peterson is involved with
the Wisconsin Chapter of the American
Academy of Pediatrics and the Section on
Administration and Practice Management.
She also cheers for Wisconsin sports —
Go Badgers and Go Packers!
Kristen Bruno, MD 03
Bruno completed four years of pediatrics
in the Air Force and is now working as a
pediatric hospitalist with GlennonCare.
Stacey Rubin, MD 06
Rubin is a generalist ob/gyn at Crozer
Keystone Health System outside
Philadelphia PA. She focuses on pediatric
and adolescent gynecology and recently
accepted a position as associate residency
director of Crozer’s ob/gyn residency
program.

In Memory
Thomas Geppert, MD 43
Geppert, 92, died on Dec. 31, 2011. He is
survived by five children and numerous
grandchildren and great-grandchildren.
Robert Stowell, PhD 44, HS 44
Stowell, a world-renowned pathologist
who was an early leader of the UC Davis
School of Medicine, died Nov. 20, 2011. He
was 96. Stowell joined UC Davis in 1967
as founding chairman of the pathology
department and was vice chairman of the
medical school’s first admissions committee. In 1969, he was appointed director of
the UC Davis Primate Center. He returned
to the pathology department after two
years and retired in 1982, but continued
teaching as a volunteer until 2001. He
was an influential leader of national and
international pathology groups.
Rosemary Etherton, NU 46
Rosemary Etherton, 85, died on Sept. 5,
2011. She continually gave of herself and
was an example of unconditional love
and grace. Her children and grandchildren
counted on her faithful prayers in every
situation. She is survived by her sister,
four daughters and 11 grandchildren.
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Jack Davis, MD 47
Davis died on Nov. 28, 2011. He was 89.
An internal medicine specialist, he was
a member of the AMA for 50 years and a
founder of the Raytown Clinic. He practiced medicine at both Research Medical
Center and Baptist Memorial Hospital. He
was a lifelong sports fan — particularly
of the Kansas City A’s, the Royals and the
Chiefs. He was a voracious reader of journals and books. He was a member of the
Raytown Christian Church.
Mary Devous, NU 48
Devous, 84, died on Oct. 10, 2011. She
retired from more than 25 years of service
in the Veterans Administration as a nurse
and nurse administrator. She also served
in many capacities in the DAV auxiliary,
the Ladies Auxiliary of Fleet Reserve
Association, Women in Military Service
for America, and in her church. She loved
nursing and caring for others, but loved
her role as mother and grandmother most.
Patricia O’Neal, LA 44, MD 48, HS
O’Neal, a retired clinical professor of psychiatry, died on Dec. 20, 2011. She was 88.
She is survived by her husband.
Rosemary Richardson, PT 48
Richardson died on Dec. 28, 2011. She is
survived by her husband and many nieces
and nephews.
Eva May Dobbins Bundenthal, NU 49
Bundenthal, 83, died on Nov. 30, 2011.
She was a registered nurse for more than
50 years and received the Humanitarian
Award for Nurse of the Year from the
Selma Medical Center.
Sidney Jick, MD 49
Jick died on Nov. 14, 2011. He is survived
by his wife, a daughter, and four grandchildren.
Joseph Iwano, MD 50
Iwano died on Oct. 28, 2011. He was 91.
After medical school and military service,
he established a private urology practice
with offices in Alliance and Salem. He was
an organic gardener decades before it was
fashionable, a skilled furniture-maker and
photographer, as well as a teller of corny
jokes. His extensive knowledge of history
made travels extra meaningful. In 1988, he
retired and moved to Mercer Island WA.

Elynor Flitz, NU 51
Flitz, 83, died on Sept. 3, 2011. She was a
registered nurse and a nurse educator. She
and her husband, Henry, lived in Princeton
for many years, later moving to Texas and
subsequently made Coralville their summer home. She is survived by her husband,
three children and six grandchildren.
James Michael, MD 53
Michael, 83, died on Nov. 10, 2011.
After an internship at Barnes Hospital
in St. Louis, he was a flight surgeon in
the U.S. Air Force. In 1960, he joined the
Department of Internal Medicine at the
Sheboygan Clinic. He served as president of the medical staff of Sheboygan
Memorial Hospital and of the Sheboygan
County Medical Society. For many years
he was the designated preceptor in the
Sheboygan area for senior medical students at the University Medical School
in Madison. Michael retired early from
medical practice to follow his passion for
watercolor painting, which he taught for
more than 30 years at the John Michael
Kohler Arts Center. He exhibited locally
and nationally and more than a thousand
of his paintings hang in private and corporate collections. Many were donated to
local charity benefit auctions.
Charles Dunaif, MD 54
Dunaif died on Dec. 26, 2011. He is
survived by his wife, daughter, and a
niece and nephew.
Byron Demorest, HS 54
Demorest died on Oct. 14, 2011. After
receiving his medical degree, he completed a residency in ophthalmology
at Washington University. He was an
assistant clinical instructor in ophthalmology at Stanford University and the
founding chairman of the Department
of Ophthalmology at the University
of California, Davis. He was a member
of many organizations, including the
American Academy of Ophthalmology for
which he served as president. He also had
active duty with the U.S. Navy, ending up
as a lieutenant commander and chairman
of the Eye Department at the Great Lakes
Naval Hospital.
Clark Grimm, MD 57
Grimm died on Sept. 13, 2011.
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R. Wayne Neal, MD 58
Neal died on Dec. 5, 2011.
Mary Coons, OT 60
Coons, 86, died on Oct. 17, 2011. She was
in the civil service in Nagoya, Japan, where
her passion for antiques and collecting
began. She returned to the United States
to finish school and retired as an occupational therapist with the VA hospital
in St. Louis MO. She was well-known on
Cherokee Antique Row in St. Louis, where
she had a store.
George Dueker, MD 61
Dueker died on Dec. 4, 2011. During the
Vietnam War he served as a flight surgeon
with the U.S. Air Force. After two years
on the Stanford faculty, he moved to
Carmel CA, where he practiced urology
for 30 years. In 2001, he affiliated with
the Provident Group in Portland OR and
became an avid Trailblazers fan. He never
stopped his quest for knowledge or
lessened his interest in the world.
Doris Rigg, OT 62
Rigg, of Denver CO, died on Sept. 25, 2011.
She was 78.
Margaret Hayes, HS 66
Hayes, of Dayton OH, died on Sept. 8,
2011. She was 84.
Thomas Banton, HS 68
Banton, 76, died on Dec. 25, 2011. He
was an orthopaedic surgeon, associated
with the Northland Orthopaedic Group
in St. Louis, and served on the staff of
De Paul Hospital and Christian Hospitals
Northeast and Northwest. He practiced
30 years before retiring in 1995. He also
served his country as a captain in the
U.S. Army. He is survived by his wife,
daughter, son and five grandchildren.
John Black, MD 73
Black, 64, died on Dec. 1, 2011. He was an
anesthesiologist and worked for Bowling
Green Anesthesia at Greenview Hospital.
He loved to cook and to attend cooking
schools. He also enjoyed travel and was
an avid photographer and reader. He was
proud of his children’s accomplishments
and of his two young grandchildren. He
also took great pride in his King Charles
spaniels, Kona and Hilo. Black is survived
by his wife Toby Black, OT 71, two
children and two grandchildren.
outlook.wustl.edu

Mark Ginsburg, LA 73, HS 81
Ginsburg, 60, died on Nov. 11, 2011, in
St. Louis MO. He attended Washington
University for his undergraduate work in
biology and returned to intern at BarnesJewish Hospital after receiving his medical
degree. Following residency, he moved to
Florida to start a rheumatology practice
and eventually became involved in other
interests including Nationwide Laboratory
Services of Fort Lauderdale FL, a revolutionary diagnostic laboratory specializing
in the needs of dialysis patients. Always
seeking the most from life, he was an avid
birder, a California wine expert, an aviation
enthusiast and an astronomer. Ginsburg
traveled extensively to South America to
help preserve and rebuild the rain forests.
He had an incredibly green thumb when
it came to his beautiful orchid garden
and also was a huge sports fan, rooting
for the Miami Hurricanes teams. Always a
research advocate, Ginsburg was honored
in 1999 as a Founders Day Distinguished
Alumni of Washington University. He was a
member of the Board of Trustees and provided scholarships to students. He is survived by his wife, son and twin daughters.
Robert Etienne, HS
Etienne died on Dec. 23, 2011. He is survived by his wife, daughters, brother
and sisters. His memory will be cherished
by his grandchildren, great-grandchildren,
nephews and a host of other family
and friends.
Bernard Sarnat, HS
Sarnat, an eminent plastic surgeon and
research scientist who advanced the
understanding of craniofacial development and the causes of facial deformities,
died on Oct. 21, 2011 in Los Angeles CA.
He was 99. In 1955, he began a private
practice in plastic surgery in Beverly Hills
CA. In 1969, he was appointed professor
of oral biology at the UCLA School of
Dentistry and, in 1974, he was appointed
professor at the UCLA School of Medicine
in the Division of Plastic Surgery. For more
than two decades, he was chief of plastic
surgery at Cedars-Sinai Medical Center. He
retired from surgical practice in 1991, but
continued writing and publishing.

Faculty
M. Alan Permutt, MD
Permutt, professor of medicine and of cell
biology and physiology at Washington
University School of Medicine, died on
June 10, 2012, in St. Louis. He was 72. A
faculty member since 1970 and one of
the world’s leading diabetes researchers,
Permutt demonstrated in 1992 that variations in the glucokinase gene could cause
type 2 diabetes. The discovery was the
culmination of years of connecting complex genetic linkage studies and molecular
biology to a common, chronic disease.
Later, his studies of genes and diabetes
led him to focus on a particularly devastating form of the illness called Wolfram
syndrome. Permutt’s laboratory identified
a gene for the illness, which causes type
1 diabetes, hearing loss, severe vision loss
and hearing and neurological problems.
In 2010, with St. Louis Children’s Hospital,
Permutt led the effort to create the world’s
first multidisciplinary clinic for patients
with Wolfram syndrome, bringing them
to St. Louis from all over the world for
intensive testing. Because the syndrome is
so rare, that first clinic in 2010 also represented the first time Permutt was able to
work directly with patients with Wolfram
syndrome and their families. Permutt
attended Johns Hopkins University in
Baltimore MD before earning a medical
degree from Washington University School
of Medicine in 1965. He later was an intern
at Yale-New Haven Hospital and a medical
resident as well as a postdoctoral fellow
at the University of Washington in Seattle
before returning to Washington University
for the rest of his academic career. He is
survived by two daughters, Joelle Permutt
and Robin Winer; dear friend Rhea
Oelbaum; four grandchildren; two sisters
and a brother.

If you wish to make a tribute gift in honor
of any of the above alumni or faculty,
please contact: Pamela Buell, Washington
University Medical Alumni and Development,
Campus Box 1247, 7425 Forsyth Blvd., Suite 2100,
St. Louis MO 63105-2161, (314) 935-9691.

Outlook 35

PLAN
to make an
IMPACT
Planned giving provides creative
strategies to support Washington University
School of Medicine in ways that often are not
possible through outright gifts. Planned gifts
also may provide significant financial and tax
benefits for the donor while ensuring critically
important programs and projects live on at the
School of Medicine. Planned gifts can be made
with cash, appreciated securities or property.
Types of planned gifts include gifts made by
will, gift annuities, charitable remainder trusts,
life insurance and bargain sales.
The benefits can include:
n Regular income payments for you and/or
your spouse or another beneficiary for life
n Charitable income tax deductions
n Gift and/or estate tax deductions or reductions
Poster session in the Farrell Learning and Teaching Center.

n Reducing, postponing or relieving capital gains tax

You can make a difference!
Pamela Buell, Associate Vice Chancellor for
Medical Alumni and Development

(314) 935-9698 or meddev@wustl.edu
K. Mark Weinrich, Executive Director of
Planned Giving
(314) 935-5203 or weinrich@wustl.edu
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Consult with your legal or tax advisor before making a charitable gift.
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Blastoff!

Fibroblasts (in bright blue), the cells that comprise
many soft tissues throughout the body, grow along
nanofabricated surgical mesh designed in a starburst
pattern. The individual nanofibers originate from a
central point and radiate outward, encouraging cells
to migrate and grow toward the center of a wound.
To learn more about this promising technology,
please turn to page 24.
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